hsa-miR-508-5p

ncRNA information

ncRNA name

hsa-miR-508-5p

Specific or universal ncRNAs

Specific ncRNAs

Class

MicroRNA

Biomarker

No

Biomarker application

Upstream regulatory factors

Not available

Downstream target

ABCB1/ZNRD1

Cancer information

Cancer name

Gastric Cancer

Cancer site

Stomach

Treatment information

Treatment type

Chemotherapy

Drug

Adriamycin/Vincristine

Impact of wild-type ncRNA on chemotherapy resistance

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Down

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

The overexpression of miR-508-5p was sufficient to reverse cancer cell resistance to multiple chemotherapeutics in vitro and sensitize tumours to chemotherapy in vivo.

Tissue resource

gastric cancer tissues

human gastric cancer cell lines SGC7901

human gastric cancer vincristine-resistant cell lines SGC7901/VCR

human gastric cancer adriamycin-resistant cell lines SGC7901/ADR

Experiment

qRT-PCR,Western blot,Luciferase reporter assay


Institute

Xijing Hospital, the Fourth Military Medical University

Country

China

Continent

Asia